The present invention is directed to hepatocyte nuclear factor 4 alpha (HNF-4 alpha) receptor modulator compounds. This invention is also directed to pharmaceutical agents comprising such compounds as well as methods of using such compounds and pharmaceutical agents for modulating HNF-4 alpha receptors as well as processes mediated by HNF-4 alpha receptors. Also provided are methods of making such compounds and pharmaceutical agents, as well as intermediates used in their synthesis.
申请公布号
WO2005010202(A2)
申请公布日期
2005.02.03
申请号
WO2004US23010
申请日期
2004.07.16
申请人
LIGAND PHARMACUETICALS INCORPORATED;MAPES, CHRISTOPHER;CHEN, JYUN-HUNG;MICHELLYS, PIERRE
发明人
MAPES, CHRISTOPHER;CHEN, JYUN-HUNG;MICHELLYS, PIERRE